Stop solution ROTI -BLACK N

Hazard statements (CLP)

H373

Code

Statements

H373

May cause damage to organs through prolonged or repeated exposure

SECTION 2: Hazards identification

According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture

Hazard categories

Cat- Hazard class and Hazard egory category statement 3.9 Specific target organ toxicity - repeated exposure STOT RE 2 H373 For full text of abbreviations: see SECTION 16

Most important adverse effects

Delayed or immediate effects can be expected after short or long-term exposure

Signal word

Warning Not required

Hazard pictograms

GHS08

Hazard statements

H373 May cause damage to organs (respiratory system) through prolonged or re- peated exposure (if inhaled) Not required

Prevention

P260 Do not breathe dust/fume/gas/mist/vapours/spray

Hazardous Ingredients

Ethylenediamine tetraacetic acid disodium salt di- hydrate Labelling of packages where the contents do not exceed 125 ml

Contains

Ethylenediamine tetraacetic acid disodium salt dihydrate Labelling of packages where the contents do not exceed 10 ml

Precautionary statements

Not required

Results of PBT and vPvB assessment

Does not contain a PBT-/vPvB-substance at a concentration of ≥ 0,1%. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.9 Specific target organ toxicity - repeated exposure 2 STOT RE 2 H373 For full text of abbreviations: see SECTION 16 The most important adverse physicochemical, human health and environmental effects Delayed or immediate effects can be expected after short or long-term exposure. 2.2 Label elements Labelling according to Regulation (EC) No 1272/2008 (CLP) Signal word Warning Pictograms GHS08 Hazard statements H373 May cause damage to organs (respiratory system) through prolonged or re- peated exposure (if inhaled) Precautionary statements Precautionary statements - prevention P260 Do not breathe dust/fume/gas/mist/vapours/spray Hazardous ingredients for labelling: Ethylenediamine tetraacetic acid disodium salt di- hydrate Labelling of packages where the contents do not exceed 125 ml Signal word: Warning Hazard pictogram(s): contains: Ethylenediamine tetraacetic acid disodium salt dihydrate Labelling of packages where the contents do not exceed 10 ml Signal word: Not required Hazard pictogram(s): Hazard statements: Not required Precautionary statements: Not required 2.3 Other hazards Results of PBT and vPvB assessment Does not contain a PBT-/vPvB-substance at a concentration of ≥ 0,1%. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%. SECTION 3: Composition/information on ingredients 3.1 Substances not relevant (mixture) 3.2 Mixtures Description of the mixture Name of sub- Identifier Wt% Classification acc. to Pictograms Notes stance GHS Ethylenediamine tet- CAS No 15 – 25 Acute Tox. 4 / H332 raacetic acid disodium 6381-92-6 STOT RE 2 / H373 salt dihydrate EC No 205-358-3 Name of sub- Identifier Specific Conc. Limits M-Factors ATE Exposure stance route Ethylenediamine CAS No - >1 mg/l/4h inhalation: tetraacetic acid 6381-92-6 dust/mist disodium salt di- hydrate EC No 205-358-3 Remarks For full text of abbreviations: see SECTION 16 SECTION 4: First aid measures 4.1 Description of first aid measures General notes Take off contaminated clothing. Following inhalation Provide fresh air. In all cases of doubt, or when symptoms persist, seek medical advice. Following skin contact Rinse skin with water/shower. Following eye contact Rinse cautiously with water for several minutes. In all cases of doubt, or when symptoms persist, seek medical advice. Following ingestion Rinse mouth. Call a doctor if you feel unwell. 4.2 Most important symptoms and effects, both acute and delayed Symptoms and effects are not known to date. 4.3 Indication of any immediate medical attention and special treatment needed none SECTION 5: Firefighting measures 5.1 Extinguishing media Suitable extinguishing media co-ordinate firefighting measures to the fire surroundings! water, foam, alcohol resistant foam, dry extinguishing powder, ABC-powder Unsuitable extinguishing media water jet 5.2 Special hazards arising from the substance or mixture Combustible. Hazardous combustion products In case of fire may be liberated: Nitrogen oxides (NOx), Carbon monoxide (CO), Carbon dioxide (CO₂), May produce toxic fumes of carbon monoxide if burning. 5.3 Advice for firefighters In case of fire and/or explosion do not breathe fumes. Fight fire with normal precautions from a reas- onable distance. Wear self-contained breathing apparatus. SECTION 6: Accidental release measures 6.1 Personal precautions, protective equipment and emergency procedures For non-emergency personnel Avoid contact with skin, eyes and clothes. Do not breathe dust. 6.2 Environmental precautions Keep away from drains, surface and ground water. Retain contaminated washing water and dispose of it. 6.3 Methods and material for containment and cleaning up Advice on how to contain a spill Covering of drains. Take up mechanically. Advice on how to clean up a spill Take up mechanically. Control of dust. Other information relating to spills and releases Place in appropriate containers for disposal. 6.4 Reference to other sections Hazardous combustion products: see section 5. Personal protective equipment: see section 8. Incom- patible materials: see section 10. Disposal considerations: see section 13. SECTION 7: Handling and storage 7.1 Precautions for safe handling Avoid dust formation. Measures to prevent fire as well as aerosol and dust generation Removal of dust deposits. Advice on general occupational hygiene Wash hands before breaks and after work. Keep away from food, drink and animal feedingstuffs. 7.2 Conditions for safe storage, including any incompatibilities Store in a dry place. Incompatible substances or mixtures Observe hints for combined storage. Incompatible materials: see section 10. Consideration of other advice: Ventilation requirements Use local and general ventilation. Specific designs for storage rooms or vessels Recommended storage temperature: 15 – 25 °C 7.3 Specific end use(s) No information available. SECTION 8: Exposure controls/personal protection 8.1 Control parameters National limit values Occupational exposure limit values (Workplace Exposure Limits) Coun Name of agent CAS No Identifi- TWA STEL Ceil- Nota- Source try er [mg/m ing-C tion ³] [mg/m ³] IE dusts, non-specific OELV 10 i S.I. No. 619 of 2001 IE dusts, non-specific OELV 4 r S.I. No. 619 of 2001 Notation Ceiling-C Ceiling value is a limit value above which exposure should not occur i Inhalable fraction r Respirable fraction STEL Short-term exposure limit: a limit value above which exposure should not occur and which is related to a 15- minute period (unless otherwise specified) TWA Time-weighted average (long-term exposure limit): measured or calculated in relation to a reference period of 8 hours time-weighted average (unless otherwise specified) Relevant DNELs of components Name of sub- CAS No End- Threshol Protection Used in Exposure time stance point d level goal, route of exposure Ethylenediamine 6381-92-6 DNEL 1,5 mg/m³ human, inhalat- worker (industry) chronic - local ef- tetraacetic acid dis- ory fects odium salt di- hydrate Ethylenediamine 6381-92-6 DNEL 3 mg/m³ human, inhalat- worker (industry) acute - local ef- tetraacetic acid dis- ory fects odium salt di- hydrate Relevant PNECs of components Name of sub- CAS No End- Threshol